Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Cocreating local actions to make healthcare more rational

Official title: Cocreating Action to Improve Rationality in the Health System

Run by Universidad Miguel Hernandez de Elche · NCT07237971 · Data updated 2026-11-12

This project will test whether working with residents in Elche to cocreate community actions can reduce unnecessary use of mental‑health drugs, cardiovascular medications, and antibiotics and ease pressure on primary care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment4000 (estimated)
SponsorUniversidad Miguel Hernandez de Elche
Academic / other
Locations2 sites (Elche, Alicante and 1 other locations)
StatusRecruiting
StartedOctober 21, 2025
Main results expectedApril 1, 2029
Study endsApril 1, 2029
Registry record updatedDecember 2, 2025
Trial IDNCT07237971 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are adults (18+) who live in Municipal District 2 of Elche or adults visiting participating community pharmacies in that district to collect antidepressants/anxiolytics, cardiovascular risk medications, or antibiotics.

Probably not a fit

People who live outside the district, those with complex or advanced conditions requiring ongoing specialist medication, or patients not engaged with local pharmacies or services are less likely to benefit directly.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This mixed-methods project partners community members, pharmacies, and regional health services in Municipal District 2 of Elche to cocreate actions targeting psychological well‑being, cardiovascular risk management, and rational antibiotic use. Researchers will run a representative population survey, survey people collecting specified medications at participating community pharmacies, analyze aggregate prescription and primary-care consultation indicators from regional electronic systems, and conduct qualitative interviews and workshops. The cocreation process aims to design community-led interventions that reduce medicalisation, improve health equity, and lower demand on primary-care services.

Why it matters

Potential benefit: If successful, patients could face fewer unnecessary prescriptions, gain more community-based supports, and experience reduced strain and waiting times in primary care.

How similar studies have gone: Community cocreation and participatory approaches have shown promise for health promotion and antibiotic stewardship in some settings, but using them specifically to reduce medicalisation at the primary-care system level is relatively novel and less well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Survey general population:

A representative population survey of adult (aged 18 years and over) who are residents in the Municipal District 2 of Elche (Spain).

Survey community pharmacies:

Individuals who visit the pharmacies collaborating in the Municipal District 2 of Elche (Spain) to obtain any of the medications, aged 18 years and over for three a priori established medication groups.

* Group 1 (Antidepressants and Anxiolytics): N05B, N05C, N06A.
* Group 2 (Cardiovascular disease risk factor medication): A10B (antidiabetics), C10A (cholesterol-lowering drugs), C07A, C09A, C03C, C08C (antihypertensives).
* Group 3 (Antibiotics): J01

Health service data from primary care:

A series of aggregate indicators will be collected from the electronic information systems of the regional health authorities (Conselleria de Sanidad de la Generalitat Valenciana), which hosts information on both prescriptions made by physicians and those dispensed in the community pharmacies of the Valencian Community. These indicators will be calculated for individuals aged 18 years and over for groups 2 and 3, and 12 years and over for group 1 using aggregate data from health system's registries and, therefore, not considering 12 years old as minimum age limit of the eligible participants in the present study protocol registry. Furthermore, aggregate data about the number of consultations will be collected in the two primary care facilities in the study area for individuals aged 18 and over.

Qualitative methods and cocreation procedure:

Focus groups, sociograms and in-depth interviews will include 6-8 participants and last approximately 90 minutes. Participation in the co-creation process will be open, voluntary, and will depend on the interest of individuals and entities in the area. Eligibility criteria:

* People aged 18 and over who are residents or have a job or family connection in the Municipal District 2 of Elche (Spain) who are interested in participating, wish to be actively involved in the co-creation, planning, and implementation of community initiatives, and are available to attend the conferences, meetings, and workshops.
* Representatives from community institutions and associations, including professionals from the Elche Public Health Center, primary care teams in the area, Elche Council staff, as well as professionals and volunteers from NGOs and other local organizations with experience in community work in the district.

Where it's running

  • Community
    Elche, Alicante, Spain
    Recruiting
  • Community based. Municipal District 2 of Elche
    Elche, Alicante, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.